
The current pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 is a significant global health challenge. A recent study by Carvelli and colleagues now demonstrates the involvement of complement C5a and its receptor C5aR1 in disease progression and suggests that blockade of the C5a-C5aR1 axis may represent a potential therapeutic strategy against COVID-19.
Immunology, Pneumonia, Viral, Complement C5a, GPCRs, drug discovery, Receptors, G-Protein-Coupled, Betacoronavirus, Immunology and Allergy, Animals, Humans, Spotlight, Pandemics, Receptor, Anaphylatoxin C5a, complement system, 2403 Immunology, SARS-CoV-2, Antibodies, Monoclonal, COVID-19, Disease Models, Animal, 2723 Immunology and Allergy, cellular signaling, Coronavirus Infections, Signal Transduction
Immunology, Pneumonia, Viral, Complement C5a, GPCRs, drug discovery, Receptors, G-Protein-Coupled, Betacoronavirus, Immunology and Allergy, Animals, Humans, Spotlight, Pandemics, Receptor, Anaphylatoxin C5a, complement system, 2403 Immunology, SARS-CoV-2, Antibodies, Monoclonal, COVID-19, Disease Models, Animal, 2723 Immunology and Allergy, cellular signaling, Coronavirus Infections, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 45 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
